Skip to main content
. 2019 Nov 5;18(6):6766–6774. doi: 10.3892/ol.2019.11051

Table IV.

FLT3-ITD mutation together with other genetic abnormalities in 75 patients with acute myeloid leukemia.

FLT3-ITH status Total (n=75) (%) Favourable-risk genes (n=46) (%) Adverse-risk genes (n=22) (%) Neither (n=7) P-value
FLT3-ITD (+) 23 (30.67) 11 (23.91) 5 (22.73) 7 (100.0%)
FLT3-ITD (-a) 52 (69.33) 35 (76.09) 17 (77.27) 0 0.914

Neither, only FLT3-ITD mutation not together with other genes; FLT3-ITD, FMS-like tyrosine kinase 3-internal tandem duplication mutation.